Posted in | News | Materials Analysis

Rigaku Announces the XtaLAB Mini II Benchtop Chemical Crystallography System

Rigaku introduces new XtaLAB mini II benchtop X-ray crystallography system for small molecule 3D molecular structure determination

X-ray scientific, analytical and industrial instrumentation manufacturer Rigaku Corporation has announced the next generation Rigaku XtaLAB mini II benchtop chemical crystallography system.

The XtaLAB mini™ II system is a research grade, compact single crystal X-ray diffractometer designed to produce ready-to-publish 3D structures with exceptional quality, exceeding IUCr publication standards.  This next-generation instrument expands the capabilities of the XtaLAB mini by the addition of a low-noise, state-of-the-art hybrid pixel array detector as well as the full-featured CrysAlisPro software from Rigaku Oxford Diffraction for instrument control and data analysis. To the user this means that poorly diffracting samples can now be measured more accurately and the set of software tools will be the same as with the top of the line diffractometers.

Positioned to be an ideal addition to any synthetic chemistry laboratory, the XtaLAB mini II enhances research productivity by offering economical structure analysis capability. New compounds can be rapidly analyzed as they are synthesized in the lab.

The newly developed detector is based on hybrid photon counting technology (HPC) and the low noise, high dynamic range and fast frame rate allow highly precise, shutterless data collection, a technique that is effective at reducing data measurement time.

The X-ray tube lifespan is extended by running at 600 W. To countervail running at lower power, a special curved monochromator is used to produce usable X-ray flux comparable to a standard X-ray system and provide the same quality data as a larger 3 kW X-ray system.

The system features the latest version of the CrysAlisPro software from Rigaku Oxford Diffraction.  CrysAlisPro is a combined instrument control and data processing package that links seamlessly to the popular Olex2 small molecule structure analysis program.

CrysAlisPro combines automated crystal screening, the fastest, most accurate strategy software available, concurrent data reduction and automatic structure solution to give the operator visual feedback in the shortest possible time. In addition to its automatic routines, CrysAlisPro includes a full complement of comprehensive and effective tools and functions for dealing with non-standard or problematic data.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rigaku Corporation. (2019, February 08). Rigaku Announces the XtaLAB Mini II Benchtop Chemical Crystallography System. AZoM. Retrieved on April 25, 2024 from https://www.azom.com/news.aspx?newsID=46103.

  • MLA

    Rigaku Corporation. "Rigaku Announces the XtaLAB Mini II Benchtop Chemical Crystallography System". AZoM. 25 April 2024. <https://www.azom.com/news.aspx?newsID=46103>.

  • Chicago

    Rigaku Corporation. "Rigaku Announces the XtaLAB Mini II Benchtop Chemical Crystallography System". AZoM. https://www.azom.com/news.aspx?newsID=46103. (accessed April 25, 2024).

  • Harvard

    Rigaku Corporation. 2019. Rigaku Announces the XtaLAB Mini II Benchtop Chemical Crystallography System. AZoM, viewed 25 April 2024, https://www.azom.com/news.aspx?newsID=46103.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.